Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Daoud L.S. Sie"'
Autor:
Egbert F. Smit, Hendrik F. van Essen, Birgit I. Lissenberg-Witte, Nicole W. J. Bulkmans, Bauke Ylstra, Julien P. L. Vincenten, Erik Thunnissen, Paul P. Eijk, Daoud L.S. Sie, Oscar Krijgsman
Publikováno v:
PLoS ONE, 14(10):e0223827. Public Library of Science
PLoS ONE
Vincenten, J P L, van Essen, H F, Lissenberg-Witte, B I, Bulkmans, N W J, Krijgsman, O, Sie, D, Eijk, P P, Smit, E F, Ylstra, B & Thunnissen, E 2019, ' Clonality analysis of pulmonary tumors by genome-wide copy number profiling ', PLoS ONE, vol. 14, no. 10, e0223827 . https://doi.org/10.1371/journal.pone.0223827
PLoS ONE, Vol 14, Iss 10, p e0223827 (2019)
PLoS ONE
Vincenten, J P L, van Essen, H F, Lissenberg-Witte, B I, Bulkmans, N W J, Krijgsman, O, Sie, D, Eijk, P P, Smit, E F, Ylstra, B & Thunnissen, E 2019, ' Clonality analysis of pulmonary tumors by genome-wide copy number profiling ', PLoS ONE, vol. 14, no. 10, e0223827 . https://doi.org/10.1371/journal.pone.0223827
PLoS ONE, Vol 14, Iss 10, p e0223827 (2019)
Multiple tumors in patients are frequently diagnosed, either synchronous or metachronous. The distinction between a second primary and a metastasis is important for treatment. Chromosomal DNA copy number aberrations (CNA) patterns are highly unique t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33b27e056277b22d0e4645ddb4363b88
https://research.vumc.nl/en/publications/91e71cdb-9431-47a4-86f4-21fbe4c2f090
https://research.vumc.nl/en/publications/91e71cdb-9431-47a4-86f4-21fbe4c2f090
Autor:
Tineke E. Buffart, Henk M.W. Verheul, Jan Dirk Burggraaf, Maarten Neerincx, Bauke Ylstra, Mark A. van de Wiel, Paul P. Eijk, Nicole C.T. van Grieken, J.H.T.M. van Waesberghe, R Shankaraiah, F. S.W. van der Wolf, Dennis Poel, Cees Verhoef, Daoud L.S. Sie
Publikováno v:
Cancer Research. 76:4928-4928
Background and aim: Patients with advanced colorectal cancer (mCRC) are commonly treated with systemic treatment consisting of fluoropyrimidine-based regimens being ineffective in 20-25% of the patients. Currently, selection criteria for patients to